Daisuke Ibi

J-GLOBAL         Last updated: May 20, 2019 at 21:01
 
Avatar
Name
Daisuke Ibi
Affiliation
Meijo University
Section
Faculty of Pharmacy
Research funding number
40757514

Research Areas

 
 

Published Papers

 
D Ibi, A Tsuchihashi, T Nomura, M Hiramatsu
European Journal of Pharmacology   842 57-63   Jan 2019   [Refereed]
Yamada S, Itoh N, Nagai T, Nakai T, Ibi D, Nakajima A, Nabeshima T, Yamada K
Journal of neuroinflammation   15(1) 295   Oct 2018   [Refereed]
*M de la Fuente Revenga, *D Ibi, Cuddy T, Toneatti R, Kurita M, Ijaz MK, Miles MF, Wolstenholme JT, González-Maeso J (* These authors contributed equally)
Neuropsychopharmacology   44(2) 443-454   Jan 2019   [Refereed]
D Ibi, F Suzuki, M Hiramatsu.
Physiology & Behavior   188 123-132   May 2018   [Refereed]
MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
AC Mitchell, B Javidfar, V Pothula, D Ibi, EY Shen, CJ Peter, L Bicks, T Fehr, Y Jiang, KJ Brennand, RL Neve, J Gonzalez-Maeso, S Akbarian.
Molecular Psychiatry   23 123-132   2018   [Refereed]
Ibi D, de la Fuente Revenga M, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, García-Bea A, Kurita M, Mosley GE, Jiang Y, Christoffel DJ, Callado LF, Russo SJ, Dracheva S, López-Giménez JF, Ge Y, Escalante CR, Meana JJ, Akbarian S, Huntley GW, González-Maeso J
Nature Neuroscience   20(9) 1247-1259   Sep 2017   [Refereed]
D Ibi, K Yamada.
International Journal of Molecular Sciences   16(12) 28218-28229   Nov 2015   [Refereed]
D Ibi, J Gonzalez-Maeso
Cellular Signalling   5(10) 2131-2136   Oct 2015   [Refereed]
Udagawa T, Fujioka Y, Tanaka M, Honda D, Yokoi S, Riku Y, Ibi D, Nagai T, Yamada K, Watanabe H, Katsuno M, Inada T, Ohno K, Sokabe M, Okado H, Ishigaki S, Sobue G
Nature communications   6 7098   May 2015   [Refereed]
Nakajima A, Ibi D, Nagai T, Yamada S, Nabeshima T, Yamada K
European journal of pharmacology   745 166-175   Dec 2014   [Refereed]
S Yamada, T Nagai, T Nakai, D Ibi, A Nakajima, K Yamada.
Brain, Behavior, and Immunity   38 272-282   May 2014   [Refereed]
Toriumi K, Ikami M, Kondo M, Mouri A, Koseki T, Ibi D, Furukawa-Hibi Y, Nagai T, Mamiya T, Nitta A, Yamada K, Nabeshima T
Journal of neuroscience research   91(12) 1525-1532   Dec 2013   [Refereed]
D Ibi, T Nagai, A Nakajima, H Mizoguchi, T Kawase, D Tsuboi, S Kano, Y Sato, M Hayakawa, UC Lange, DJ Adams, MA Surani, T Satoh, A Sawa, K Kaibuchi, T Nabeshima, K Yamada.
GLIA   61(5) 679-693   May 2013   [Refereed]
Mouri A, Nagai T, Ibi D, Yamada K
Neurobiology of disease   53 61-74   May 2013   [Refereed]
Zhang L, Nagai T, Yamada K, Ibi D, Ichihara S, Subramanian K, Huang Z, Mohideen SS, Naito H, Ichihara G
Toxicology   304 76-82   Feb 2013   [Refereed]
Nagai T, Yun J, Ibi D, Koike H, Hibi Y, Yamada K
Nihon yakurigaku zasshi. Folia pharmacologica Japonica   139(4) 147-151   Apr 2012   [Refereed]
Takuma K, Mizoguchi H, Funatsu Y, Kitahara Y, Ibi D, Kamei H, Matsuda T, Koike K, Inoue M, Nagai T, Yamada K
Journal of pharmacological sciences   120(2) 89-97   2012   [Refereed]
Kuroda K, Yamada S, Tanaka M, Iizuka M, Yano H, Mori D, Tsuboi D, Nishioka T, Namba T, Iizuka Y, Kubota S, Nagai T, Ibi D, Wang R, Enomoto A, Isotani-Sakakibara M, Asai N, Kimura K, Kiyonari H, Abe T, Mizoguchi A, Sokabe M, Takahashi M, Yamada K, Kaibuchi K
Human molecular genetics   20(23) 4666-4683   Dec 2011   [Refereed]
[PolyI:C-induced neurodevelopmental animal model for schizophrenia].
Ibi D, Nagai T, Nabeshima T, Yamada K
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology   31(5-6) 201-207   Nov 2011   [Refereed]
Nagai T, Kitahara Y, Ibi D, Nabeshima T, Sawa A, Yamada K
Behavioural brain research   225(1) 305-310   Nov 2011   [Refereed]